SCHEMBL7755148

SCHEMBL7755148

CCCCOC(=O)N[C@@H](C(=O)O)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
PLA2G2A P14555 1/20 0.51
PLA2G5 P39877 1/20 0.51
PPARG P37231 2/20 0.51
PPARA Q07869 1/20 0.51
MAPT P10636 1/20 0.46
HSD17B10 Q99714 1/20 0.46
EPHX1 P07099 1/20 0.44
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
ACHE P22303 6/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TYR P14679 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1287155 1.00 SMN1; SMN2 (0.53) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL509967 1.00 SMN1; SMN2 (0.53) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL8467616 0.95 SMN1; SMN2 (0.55) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL8466581 0.95 SMN1; SMN2 (0.55) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL9828390 0.95 SMN1; SMN2 (0.55) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL10481485 0.94 SMN1; SMN2 (0.48) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL10481483 0.94 SMN1; SMN2 (0.48) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL7770760 0.93 PLA2G2A (0.56) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL7770749 0.93 PLA2G2A (0.56) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA
SCHEMBL7770751 0.93 PLA2G2A (0.56) SMN1; SMN2PLA2G2APLA2G5PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3265448-A1 RILUZOLE PRODRUGS AND THEIR USE Biohaven Pharmaceutical Holding Company Ltd. (US) 2018-01-10 EP disclosed
WO-2016140879-A9 RILUZOLE PRODRUGS AND THEIR USE BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. (US) 2016-11-03 WO disclosed
WO-2016140878-A9 PRODRUGS RILUZOLE AND THEIR METHOD OF USE BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. (US) 2016-10-20 WO disclosed
EP-1087935-A1 ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS BTG INTERNATIONAL LIMITED (GB) 2001-04-04 EP disclosed
WO-1999065866-A1 ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS BTG INTERNATIONAL LIMITED (GB) 1999-12-23 WO disclosed